IMPACT OF SMOKING HISTORY ON THE REAL-WORLD EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER: A NATIONWIDE POPULATION-BASED STUDY

被引：0
|
作者：
Lee, J. [1 ]
Kim, Y. [2 ,3 ]
Suh, H. S. [4 ]
机构：
[1] Kyung Hee Univ, Inst Regulatory Innovat Sci, Grad Sch, Dept Regulatory Sci, Seoul, South Korea
[2] Kyung Hee Univ, Inst Regulatory Innovat Sci IRIS, Coll Pharm, Seoul, South Korea
[3] Univ Texas Austin, Coll Pharm, Hlth Outcomes Div, Austin, TX USA
[4] Kyung Hee Univ, Inst Regulatory Innovat Sci, Coll Pharm, Dept Regulatory Sci,Grad Sch, Seoul, South Korea
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Proton Pump Inhibitors' Impact on the Effectiveness of Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer
    Edwards, A. L.
    Walker, D.
    Dumais, K.
    Powery, H.
    Linares, J.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S634 - S635
  • [22] Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy
    Schwartzberg, Lee
    Korytowsky, Beata
    Penrod, John R.
    Zhang, Ying
    Le, T. Kim
    Batenchuk, Cory
    Krug, Lee
    CLINICAL LUNG CANCER, 2019, 20 (04) : 287 - +
  • [23] Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
    Fu-Xiao Li
    Jia-Xin Cai
    Ji-Bin Li
    Kong-Jia Luo
    Shi-Yu Wang
    Wei-Hua Meng
    Feng Sha
    Zhi-Rong Yang
    Allan Hackshaw
    Jin-Ling Tang
    Cardio-Oncology, 11 (1)
  • [24] NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' Study
    Buja, Alessandra
    Rugge, Massimo
    Bortolami, Alberto
    Zorzi, Manuel
    Rea, Federico
    Zanovello, Anna
    Scroccaro, Giovanna
    Conte, Pierfranco
    Pasello, Giulia
    Guarneri, Valentina
    CANCERS, 2025, 17 (04)
  • [25] Induction immune checkpoint inhibitors and chemotherapy for patients with stage III non-small cell lung cancer: A real-world experience
    Zheng, Shuohan
    Sun, Ciming
    Zhang, Hao
    Xu, Huimin
    Dong, Baiqiang
    Hou, Zan
    Chen, Ming
    Li, Qiwen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [27] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [28] Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)
    Iranzo, P.
    Callejo, A.
    Marmolejo, D.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S767 - S767
  • [29] Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway
    Gartner, Fabian
    Assmus, Jorg
    Flotten, Oystein
    Ramnefjell, Maria Paula
    Aanerud, Marianne
    ACTA ONCOLOGICA, 2022, 61 (07) : 814 - 818
  • [30] REAL-WORLD INCIDENCE AND IMPACT OF PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Tiu, Bruce
    Zubiri, Leyre
    Iheke, James
    Pahalyants, Vartan
    Theodosakis, Nicholas
    Ugwu-Dike, Pearl
    Seo, Jayhyun
    Tang, Kimberly
    Sullivan, Ryan
    Mooradian, Meghan
    Semenov, Yevgeniy
    Reynolds, Kerry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A841 - A841
12345